Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. On August 16, 2022, Endo International plc, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.
Show more...
CEO
Blaise Coleman
Zamestnanci
2931
Krajina
Írsko
ISIN
IE00BJ3V9050
WKN
000A1XE6M
Zalistovania
0 Comments
Podeľ sa o svoj názor
FAQ
Aká je dnes cena akcie spoločnosti Endo International?▼
Aktuálna cena ENDPQ je $0,00 USD — za posledných 24 hodín vzrástla o +0%. Vývoj ceny akcie spoločnosti Endo International môžete podrobnejšie sledovať v grafe.
Aký ticker má akcia spoločnosti Endo International?▼
Ticker akcie sa môže líšiť podľa burzy. Napríklad na burze sa akcie spoločnosti Endo International obchodujú pod tickerom ENDPQ.
Aké boli tržby spoločnosti Endo International za minulý rok?▼
Tržby spoločnosti Endo International za posledný rok predstavujú 2,01B USD.
Aký je čistý zisk spoločnosti Endo International za minulý rok?▼
Čistý zisk ENDPQ za posledný rok predstavuje -2,45B USD.
Koľko má Endo International zamestnancov?▼
Ku dňu júna 11, 2026 má spoločnosť 2 931 zamestnancov.
Do akého sektora patrí Endo International?▼
Endo International pôsobí v sektore Technology.
Kedy spoločnosť Endo International uskutočnila split akcií?▼
Spoločnosť Endo International v poslednom čase neuskutočnila žiadny split akcií.
Kde má Endo International sídlo?▼
Endo International má sídlo v meste Dublin, Írsko.